Wragge Lawrence Graham & Co
- Corporate (31)
- Funds (19)
- Real Estate (17)
- Banking / Finance (16)
- Information Technology (12)
- Financial services (9)
- Intellectual Property (9)
- Pharma/Biotech (9)
- PPP/PFI/Commercial projects (9)
- Construction (8)
- Employment (8)
- Tax (8)
- Regulatory and compliance (7)
- Energy (6)
- Pensions (6)
- Public Sector/Local Authority (6)
- Competition/EU (5)
- Litigation / Dispute Resolution (5)
- Planning (5)
- Private Equity (5)
- Healthcare (4)
- Telecoms (4)
- Business Tax (3)
- Environment (3)
- Insurance/reinsurance (3)
- Insolvency & restructuring (2)
- Media/Entertainment/Sport (2)
- Personal tax / Trusts (2)
- Transport (Including aviation and shipping) (2)
- Travel and Tourism (2)
- Commodities (1)
- In-House (1)
- Licensing/Gaming/Betting (1)
- Private Client (1)
Sort By: Newest first | Oldest first
The investment funds team at Wragge Lawrence Graham & Co has acted on half of the IPOs and significant secondary issues for listed investment companies in the first half of 2015.
Wragge Lawrence Graham & Co’s life sciences experts have advised AstraZeneca on its definitive agreement with Genzyme to divest Caprelsa (vandetanib), a rare disease medicine.
Wragge Lawrence Graham & Co has provided Empiric Student Property plc (Empiric) with advice on its first corporate acquisition, at a value of £41.6m.
Wragge Lawrence Graham & Co’s intellectual property experts in Munich have worked with Ashurst LLP to advise Novacap Group on its acquisition of pharmaceutical company CU Chemie Uetikon.
Wragge Lawrence Graham & Co has advised AstraZeneca on a co-development and commercialisation agreement with Innate Pharma SA, a biopharmaceutical company developing therapeutic antibodies for the treatment of cancer.
Wragge Lawrence Graham & Co’s investment funds team has advised AEW UK REIT Plc on a fundraising worth £100m.
Wragge Lawrence Graham & Co’s tech team has helped new client Breezie to secure investment from the Ziegler LinkAge Longevity Fund.
Wragge Lawrence Graham & Co’s banking and finance team have advised the North West Evergreen Fund on its £15m investment to Allied London to part-fund the development of No.1 Spinningfields in Manchester.
A team from the banking and finance department has advised Harworth Estates Property Group on the refinancing of its group banking facilities.
Wragge Lawrence Graham & Co’s investment funds team has advised Empiric Student Property plc on an £85m fund raising, exceeding its target of approximately £75m.
Wragges has advised long-standing client on a three-year drug discovery collaboration agreement with Orca.
Wragge Lawrence Graham & Co has advised longstanding client Société Générale Capital Partners on the leveraged buyout of specialty chemicals distributor Safic-Alcan from Parquest Capital.
Wragge Lawrence Graham & Co has advised GlaxoSmithKline (GSK) on the sale of its shareholding interests in biopharmaceutical company Convergence Pharmaceuticals to Biogen Idec.
Wragge Lawrence Graham & Co secures a High Court win over design rights for worldwide denim specialist G-Star Raw.
Wragge Lawrence Graham & Co has advised high-street retailer and long-standing client Argos on its arrangement with Sainsbury’s to launch a series of new Argos digital stores within a number of its UK supermarkets.
Wragge Lawrence Graham & Co has advised Birmingham City Council on the sale of the NEC Group to LDC.
The energy & infrastructure dinance team at Wragge Lawrence Graham & Co has advised longstanding client Primrose Solar on two inflation-linked financings.
Wragge Lawrence Graham & Co has advised Riviera Travel on a significant investment made into the company by private equity firm, Phoenix Equity Partners.
Sarah Sasse, who leads Wragge Lawrence Graham & Co’s public sector IT/outsourcing practice, has been named in the 2014 Power Part Time list.
Wragge Lawrence Graham & Co’s solar energy specialists have advised RGE Energy on the disposal of a solar project.